Abstract
The melastatin transient receptor potential (TRP) channel, TRPM4, is a critical regulator of smooth muscle membrane potential and arterial tone. Activation of the channel is Ca2+-dependent, but prolonged exposures to high global Ca2+ causes rapid inactivation under conventional whole-cell patch clamp conditions. Using amphotericin B perforated whole cell patch clamp electrophysiology, which minimally disrupts cytosolic Ca2+ dynamics, we recently showed that Ca2+ released from inositol trisphosphate receptors (IP3R) on the sarcoplasmic reticulum (SR) activates TRPM4 channels, producing sustained Transient Inward Cation Currents (TICCs). Thus, Ca2+-dependent inactivation of TRPM4 may not be inherent to the channel itself but rather is a result of the recording conditions. We hypothesized that under conventional whole-cell configurations, loss of intrinsic cytosolic Ca2+ buffering following cell dialysis contributes to inactivation of TRPM4 channels. With the inclusion of the Ca2+ buffers ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA, 10 mM) or bis-ethane-N,N,N′,N′-tetraacetic acid (BAPTA, 0.1 mM) in the pipette solution, we mimic endogenous Ca2+ buffering and record novel, sustained whole-cell TICC activity from freshly-isolated cerebral artery myocytes. Biophysical properties of TICCs recorded under perforated and whole-cell patch clamp were nearly identical. Furthermore, whole-cell TICC activity was reduced by the selective TRPM4 inhibitor, 9-phenanthrol, and by siRNA-mediated knockdown of TRPM4. When a higher concentration (10 mM) of BAPTA was included in the pipette solution, TICC activity was disrupted, suggesting that TRPM4 channels on the plasma membrane and IP3R on the SR are closely opposed but not physically coupled, and that endogenous Ca2+ buffer proteins play a critical role in maintaining TRPM4 channel activity in native cerebral artery smooth muscle cells.
1. INTRODUCTION
The melastatin (M) Transient Receptor Potential (TRP) channel TRPM4 is a crucial mediator of pressure-induced vascular smooth muscle membrane depolarization and vasoconstriction, and is essential for autoregulation of cerebral blood flow [1, 2]. High levels of intracellular Ca2+ (1–10 μM) are required for activation of TRPM4 [3], and under inside-out [1, 4, 5] or traditional whole cell patch configuration [3, 6], Ca2+ is introduced in order to activate and record TRPM4 currents. However, under these conditions TRPM4 also undergoes fast, Ca2+-dependent inactivation, and currents decay to baseline levels within 3 minutes [1, 4, 7–9]. TRPM4 channel activity can be rescued from inactivation by inhibition of phospholipase C (PLC) activity or by inclusion of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) in the intracellular solution [10, 11]. These findings suggest that high global levels of Ca2+ used to record TRPM4 currents in traditional whole cell and inside-out patch clamp configurations activate a Ca2+-dependent PLC isoform [12] that inactivates the channel by depleting PIP2. It is possible that Ca2+-dependent inactivation precludes observation of TRPM4 currents during patch clamp experiments, leading to under-estimation of channel activity under native conditions. We recently identified Transient Inward Cation Currents (TICCs) as sustained TRPM4 channel activity in freshly isolated smooth muscle cells [13]. These currents can be continuously recorded for as long as 30 minutes using the whole cell perforated patch clamp configuration [13], a method that restricts cell dialysis and causes minimal disruption of the intracellular environment, allowing global and local Ca2+ dynamics to function naturally. Thus, Ca2+-dependent inactivation of TRPM4 may not be an inherent property of the channel itself but is a consequence of recoding methods. However, the mechanisms underlying this phenomenon are not clear. The goal of the current study is to determine how Ca2+-dependent activation of TRPM4 currents is maintained in cerebral artery smooth muscle cells under native conditions.
Subcellular regions with Ca2+ levels much greater than the global [Ca2+] result from Ca2+ influx from the extracellular space [14, 15] or from Ca2+ released from intracellular stores [16–19]. The temporal and spatial characteristics of these small Ca2+ domains are shaped by the magnitude and duration of the initial Ca2+ signal, and by Ca2+ removal and intrinsic Ca2+ buffering within the cytosol [20]. For example, the plasma membrane Ca2+-ATPase (PMCA), the Na+/Ca2+ exchange system, the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), and Ca2+ sequestering in the mitochondria and nucleus [20] all actively remove Ca2+ from the intracellular space. Additionally, cytosolic proteins, such as calmodulin, calpain, and troponin C, bind Ca2+ and limit the availability of free intracellular Ca2+ [21]. These Ca2+ buffering mechanisms are essential for insuring the transient nature of intracellular Ca2+ signaling events by limiting spatial spread and preventing prolonged high cytosolic Ca2+ levels.
Localized, transient increases in cytosolic Ca2+ can directly activate Ca2+-sensitive ion channels [17, 22] in vascular smooth muscle cells. Our laboratory recently reported loss of TRPM4 channel activity following specific inhibition of the SR inositol Ca2+ release channel, 1,4,5-trisphosphate receptor (IP3R) [13], suggesting that subcellular cytosolic Ca2+ domains also activate TRPM4 channels in the plasma membrane in native smooth muscle cells. However, the role of endogenous Ca2+ buffering in regulation of TRPM4 activity has not been reported. We hypothesized that under conventional whole cell conditions, loss of intrinsic cytosolic Ca2+ buffering following cellular dialysis contributes to Ca2+-dependent inactivation of TRPM4 channels. To test this hypothesis, we examined the consequences of manipulating intracellular Ca2+ buffering on TRPM4 activity in freshly isolated cerebral myocytes. In the absence of cytosolic Ca2+ buffering, we found that TICC activity quickly dissipated with the same inactivation kinetics as recombinant TRPM4 activity recorded in the presence of high global Ca2+ under conventional whole cell conditions. Using conventional whole cell patch clamp electrophysiology, we recorded sustained, TICC-like currents (whole-cell TICCs) with ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) or 2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) added to the intracellular recording solution at concentrations (10 and 0.1 mM, respectively) that mimic the effects of endogenous Ca2+ buffering. These currents were pharmacologically and biophysically identical to TRPM4-dependent currents recorded under perforated patch clamp conditions. Higher concentrations of BAPTA abolished these currents, demonstrating that TRPM4 channels are present on the plasma membrane very near, but not physically coupled to, IP3Rs. This conclusion is supported by TRPM4 and IP3R immunolabeling experiments. This study demonstrates that intact endogenous Ca2+ buffering is required to maintain TRPM4 channel activity in smooth muscle cells.
2. MATERIAL AND METHODS
2.1. Animals
Male Sprague-Dawley rats (250–350 g; Harlan) were used for these studies. Animals were deeply anesthetized with pentobarbital sodium (50 mg ip) and euthanized by exsanguination according to a protocol approved by the Institutional Animal Care and Use Committees (IACUC) of Colorado State University. Brains were isolated in cold 3-(N-morpholino) propanesulfonic acid (MOPS)-buffered saline (in mM): 3 MOPS (pH 7.4), 145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 2 pyruvate, and 5 glucose and 1% bovine serum albumin. Cerebral and cerebellar arteries were dissected from the brain, cleaned of connective tissue, and stored in MOPS-buffered saline prior to further manipulation.
2.2. A7r5 Cell Culture and Transient DNA Transfection
A7r5 cells (ATCC) were cultured in Dulbecco’s 1X High Glucose Modified Eagle Medium (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 0.5% penicillin-streptomycin (Gibco). Cells were maintained at 37°C with 6% CO2, media was changed every two to three days, and cells were sub-cultured when confluent using 0.25% trypsin-EDTA (Gibco). A7r5 cells were transiently transfected with a plasmid encoding a TRPM4-GFP fusion protein [23] with the aid of Effectene Transfection Reagent (Qiagen) according to manufacturer’s instructions for adherent cells. Media was changed 24 hours after transfection, and cells were cultured for 1–2 days prior to electrophysiology experiments.
2.3. Isolation of Cerebral Artery Smooth Muscle Cells
Vessels were placed on ice in a magnesium-based physiological saline solution (Mg-PSS) containing (in mM) 5 KCl, 140 NaCl, 2 MgCl2, 10 HEPES, and 10 glucose. Arteries were initially digested in 0.6 mg/mL papain (Worthington) and 1 mg/mL dithioerythritol at 37°C for 17 minutes, followed by a 15 minute incubation at 37°C in 1.0 mg/ml type II collagenase (Worthington). The digested segments were washed three times in ice-cold Mg-PSS solution and incubated on ice for 30 minutes. Following this incubation period, vessels were triturated to liberate smooth muscle cells and stored in ice-cold Mg-PSS for use. Smooth muscle cells were studied within 6 hours following isolation.
2.4. RNAi and Reversible Permeabilization
Small interfering RNAs (siRNA) against TRPM4 were used to down-regulate expression of the channel in isolated cerebral arteries [13]. siRNA molecules purchased from Qiagen (1027280 [AllStars Negative Control], SI02868292 [Rn_Trpm4_1], and SI02868313 [Rn_Trpm4_4]) were dissolved as instructed at a concentration of 20 μM in siRNA Suspension Buffer. Control siRNA or TRPM4 siRNA molecules were introduced into intact cerebral arteries using a reversible permeabilization procedure. To permeabilize the arteries, segments were first incubated for 20 minutes at 4°C in the following solution (in mM): 120 KCl, 2 MgCl2, 10 EGTA, 5 Na2ATP, and 20 TES; (pH 6.8). Arteries were then placed in a similar solution containing siRNA (40 nM) for 3 hours at 4°C and then transferred to a third siRNA-containing solution with elevated MgCl2 (10 mM) for 30 minutes at 4°C. Permeabilization was reversed by placing arteries in a MOPS-buffered physiological siRNA-containing solution consisting of (in mM): 140 NaCl, 5 KCl, 10 MgCl2, 5 glucose, and 2 MOPS; (pH 7.1) for 30 minutes at room temperature. Ca2+ was gradually increased in the latter solution from nominally Ca2+-free to 0.01, 0.1, and 1.8 mM over a 45 minute period. Following these procedures, arteries were cultured for two to three days in D-MEM/F-12 culture media supplemented with L-glutamine (2 mM) (Gibco), and 0.5% penicillin-streptomycin (Gibco). Arteries were then used for smooth muscle cell isolation.
2.4. Immunocytochemistry and Membrane Staining
Cells were enzymatically dissociated from cerebral vessels as described above, and allowed to adhere to glass slides for 20 minutes at 4°C. Cells were fixed with 4% formaldehyde for 10 minutes, permeabilized with cold methanol (−80°C), blocked with 2% bovine serum albumin, and incubated with primary antibodies overnight at 4°C. The following primary antibodies were used as appropriate: goat anti-TRPM4 at 1:50 (sc-27540, Santa Cruz) and rabbit anti-IP3R at 1:50 (AB1622, Chemicon). Cells were subsequently washed and incubated with appropriate fluorescent secondary antibody for 2 hours at room temperature. The following secondary antibodies were used as appropriate; anti-rabbit conjugated to Texas Red, (sc-2780, Santa Cruz) and anti-goat conjugated to FITC, (sc-2704, Santa Cruz). Membrane specific fluorescent staining was performed using 5 μg/mL ER-Tracker™ Green (Invitrogen), 5 μg/mL ER-Tracker™ Red (Invitrogen), or 5 μg/mL CellMask™ Deep Red (Invitrogen). For specific plasma membrane staining, cells were incubated in CellMask™ Deep Red in Mg-PSS for 10 minutes at 37°C. For specific SR membrane staining, cells were incubated in ER-Tracker™ Green or ER-Tracker™ Red in MgPSS for 30 minutes at 37°C. For dual membrane staining, the cells were incubated in ER membrane stain, washed, and incubated in plasma membrane stain. For simultaneous immunocytochemistry and membrane staining, fixed cells were first immunolabeled for the appropriate protein and then incubated in the specific membrane stain. Fluorescent images were obtained using a spinning disk confocal microscope (Andor) and a 100x oil immersion objective. Excitation of Texas Red and FITC was by illumination with the 543-nm line and 488-nm line, respectively. Immunofluorescence was not detected in cells probed with secondary antibody alone. All images were acquired at 1024×1024 pixels and were analyzed using Volocity 6.0 (PerkinElmer).
2.5. General Electrophysiological Recordings
Currents were recorded using an AxoPatch 200B amplifier equipped with an Axon CV 203BU headstage (Molecular Devices). Recording electrodes (1–3 MΩ) were pulled, polished, and coated with wax to reduce capacitance. Currents were filtered at 1 kHz, digitized at 40 kHz, and stored for subsequent analysis. Clampex and Clampfit versions 10.2 (Molecular Devices) were used for data acquisition and analysis, respectively. All experiments were performed at room temperature (22°C).
2.6. Electrophysiological Recording Solutions
Macroscopic whole cell currents from HEK 293 cells transfected with TRPM4-GFP were recorded in external bathing solution containing (in mM): 146 NaCl, 5 CaCl2, 10 HEPES, and 10 Glucose (pH = 7.4). The bathing solution was supplemented with the potassium channel blocker TEA (10 mM). The pipette solution contained (in mM): 146 CsCl, 1 MgCl2, 10 HEPES and 0.1CaCl2. TICC activity recorded under perforated patch clamp conditions was performed in external bathing solution containing (in mM): 134 NaCl, 6 KCl, 1 MgCl2 2 CaCl2, 10 HEPES, and 10 glucose at pH 7.4 (NaOH). The pipette solution contained (in mM): 110 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 HEPES, and 5 μM EGTA at pH 7.2 (NaOH). TICC activity recorded under whole-cell patch clamp conditions was performed in external bathing solution containing (in mM): 140 NaCl, 5 CsCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose at pH of 7.4 (NaOH). The pipette solution contained (in mM): 20 CsCl, 87 K-aspartate, 1 MgCl2, 5 MgATP, and 10 HEPES (pH 7.2, CsOH). External solution with the K+ channel blocker tetraethylammonium (TEA) contained (in mM): 130 NaCl, 10 TEA, 5 CsCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose at pH 7.4. Additional external solutions include, Na+-free external solution containing (in mM): 140 N-methyl-D-glucamine (NMDG), 5 CsCl2, 1 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose at pH 7.4 (HCl); and Ca2+ free external solution containing (in mM): 130 NaCl, 5 CsCl2 1 MgCl2 0.73 CaCl2, 1 EGTA, 10 HEPES, and 10 glucose at pH 7.4 (NaOH).
2.7. Electrophysiological Recordings from TRPM4-Expressing A7r5 Cells
Conventional whole cell patch clamp studies were conducted using non-transfected A7r5 cells or cells transiently transfected with TRPM4-GFP [23]. Transfected cells were identified by the presence of green fluorescence. Cells were initially held at a membrane potential of 0 mV. Currents were measured during voltage ramps between −100 and +100 mV (time of ramp) repeated every 4 seconds.
2.8. Electrophysiological Recordings from Isolated Smooth Muscle Cells
Freshly isolated cerebral artery smooth muscle cells were placed into a recording chamber (Warner Instruments) and allowed to adhere to glass coverslips for 20 minutes at room temperature. GΩ seals were obtained in Mg-PSS. For perforated whole cell patch clamp recordings, amphotericin B (40 μM) was included in the pipette solution. Perforation was deemed acceptable if series resistance was less than 50 MΩ. For conventional whole cell patch clamp recordings, isolated smooth muscle cells were voltage clamped at a membrane potential (Em) of −70 mV. In our recording solutions, the calculated reversal potential for total monovalent cations is 7.7 mV and −48.9 mV for monovalent anions (Cl−). TICC activity at −70 mV was calculated as the sum of the open channel probability (NPo) of multiple open states with unitary amplitude of 1.75 pA (i.e. 1 open state). This value was based on the reported unitary conductance of TRPM4 (25 pS).
Channel open probability (NPo) was calculated using the following equation:
Where:
tj = time spent in seconds with j = 1,2,....N channels open
N = max number of channels observed
T = duration of measurement.
2.9. Calculations and Statistics
All data are means ± SE. Values of n refer to the number of cells for patch clamp experiments. Data were compared as indicated using paired t-tests or one-way repeated measures analysis of variance (ANOVA). A level of P ≤ 0.05 was accepted as statistically significant for all experiments. All peak amplitude histograms were constructed using Origin 8.1 (OriginLab Corp.).
3. RESULTS
3.1. Disruption of the Intracellular Environment Leads to Ca2+-Dependent TRPM4 Inactivation
Under traditional whole cell patch clamp configurations, TRPM4 currents recorded from recombinant channels expressed in HEK 293 cells, or from native channels in freshly isolated cerebral artery myocytes, exhibit rapid, Ca2+-dependent inactivation [3, 6]. To better characterize the time course of TRPM4 inactivation we compared recombinant macroscopic TRPM4 currents from smooth muscle-derived A7r5 cells and native TRPM4 channel activity in freshly-isolated smooth muscle cells. Currents were obtained from A7r5 cells transfected with TRPM4-GFP [23] using the conventional whole cell configuration with 100 μM Ca2+ included in the patch pipette solution. As expected, in the presence of high cytosolic Ca2+ levels, cation currents exhibited outward rectification and rapid inactivation (Figure 1A). Peak TRPM4-GFP currents (black arrowhead, n=5) decreased by 26 ± 6% at 8 seconds (grey arrowhead) and 60 ± 5% at 60 seconds (white arrowhead). These findings are consistent with previous reports of TRPM4 channel activity in HEK 293 cells [3, 6] and demonstrate that recombinant TRPM4 channel currents in A7r5 cells quickly dissipate following prolonged exposure to high global Ca2+.
Figure 1. The Kinetics of Ca2+-Dependent TRPM4 Desensitization are Similar in A7r5 and Freshly Isolated Smooth Muscle Cells.
A: Current/Voltage (I/V) relationship showing total current at 8 (grey arrowhead) and 60 seconds (white arrowhead) after peak (black arrowhead) in A7r5 cells expressing TRPM4-GFP and non-transfected cells (*). Cells were recorded under conventional whole cell patch clamp conditions (WC) with 100 μM Ca2+ added to the pipette solution. B: Representative trace of Transient Inward Cation Currents (TICC) activity recorded from a freshly isolated cerebral artery smooth muscle cell (SMC) under perforated whole cell patch clamp conditions (PP). Membrane potential = −70 mV. C: Representative trace of TICC-like activity recorded from a freshly isolated cerebral artery smooth muscle cell under conventional whole cell patch clamp conditions when no Ca2+ buffer is present in the intracellular solution. Membrane potential = −70 mV. D: Time course of inactivation of TRPM4 currents (at +70 mV) in A7r5 cells (n=6), TICC activity recorded under perforated patch clamp conditions (n=8), and TICC-like currents recorded under whole-cell conditions in native myocytes (n=5) as a fraction of the peak current following cellular dialysis.
In native cerebral artery smooth muscle cells patch clamped under perforated patch conditions (leaving the intracellular environment undisturbed), TRPM4 currents manifest as TICCs. TICCs can be recorded under perforated patch conditions for as long as seal integrity can be maintained. We recorded TICC activity under perforated patch clamp conditions (PP, Figure 1B) and TICC-like currents under conventional whole cell patch clamp (WC, Figure 1C) configuration without the addition of Ca2+ to the pipette solution. TICCs recorded under perforated patch conditions did not inactivate, while under whole cell conditions we observed time-dependent decay of TICC-like activity. Activity decreased by 16 ± 10% at 10 seconds and by 64 ± 6% at 60 seconds following cellular dialysis. The time course of inactivation of whole cell TRPM4 currents recorded from A7r5 cells (Figure 1A) and the decay of TICC activity in native cerebral artery smooth muscle cells (Figure 1B) are identical (Figure 1C), suggesting that inactivation results from a common mechanism. Furthermore, these findings are consistent with the hypothesis that in freshly isolated smooth muscle cells patch clamped under whole cell conditions, cytosolic Ca2+ levels are increased following cellular dialysis, disruption of the intracellular environment, and loss of intrinsic Ca2+ buffering.
3.2. EGTA Emulates Endogenous Cytosolic Ca2+ Buffering
To examine the hypothesis that loss of intracellular Ca2+ buffering capacity during cellular dialysis under conventional whole cell conditions results in TRPM4 inactivation, we used established software (CalC version 6.0, [24]) to model the effects of different concentrations of the slow Ca2+ buffer EGTA on the linear spread of Ca2+released from a single IP3R (Ca2+ puff). The current strength and on- and off-times of Ca2+ puffs were assumed to be 0.2 pA, 17 ms, and 100 ms, respectively, [25, 26] and resting, free global Ca2+ was assumed to be 200 nM with a diffusion coefficient of 200 μMs−1 [27]. Ca2+ movements during three buffering states were modeled: no buffering, endogenous smooth muscle cell buffering, and buffering with EGTA. As a first order approximation, we modeled endogenous cytosolic Ca2+ buffering capacity of a cell with the mean of reported values (Table 1) for the most abundant Ca2+ binding protein calmodulin (CaM) at a reported concentration of 40 μM in smooth muscle cells [28]. Additionally, our model used the reported values for the diffusion coefficient, Ca2+ affinity, dissociation constant, and Ca2+ on- and off-rates for CaM and EGTA (Table 1) [27–31] and compared the diffusion of free Ca2+ within model cells containing different concentrations of EGTA with those of cells with endogenous buffering.
Table 1.
Buffer Parameters
| Parameters | Endogenous | BAPTA | EGTA |
|---|---|---|---|
| Diffusion Coefficient (μm2s−1) | 20 | 220 | 200 |
| Ca2+ affinity (Kd) (nM) | 200 | 150 | 150 |
| Dissociation constant βF/αF (μM) | 10 | 0.22 | 0.15 |
| Ca2+ On-rate αF (μM−1s−1) | 1 | 400 | 5 |
| Ca2+ Off-rate βF (s−1) | 10 | 80 | 0.75 |
In cells modeled with endogenous Ca2+ buffering, Ca2+ levels decreased logarithmically with distance from the Ca2+ source (Figure 2). Cells modeled with no Ca2+ buffering elicit a nearly linear relationship between [Ca2+] and the distance traveled from the Ca2+ source (Figure 2). Thus, in the absence of Ca2+ buffering, Ca2+ levels are greater at any given point away from the Ca2+ source than what is predicted for native endogenous buffering conditions. The no buffer condition models the conventional whole-cell patch clamp conditions used for the recording shown in Figure 1B, resulting in time-dependent inactivation of TRPM4 currents. Thus, it is possible that TRPM4 inactivation under these conditions results from loss of endogenous Ca2+ buffering. The effects of EGTA were also examined in our modeling experiments. These findings predict that at a concentration of 10 mM the buffering capacity of EGTA has the same effect on the spatial spread of Ca2+, up to 100 nm, as projected for endogenous intracellular Ca2+ buffers (Figure 2).
Figure 2. Endogenous Ca2+ Buffering Can be Mimicked with EGTA.
Modeling the effects of endogenous buffering capacity and different concentrations (1 and 10 mM) of the slow Ca2+ chelator EGTA on [Ca2+] as a function of distance from a single IP3R Ca2+ release site.
3.3. Sustained TRPM4 Currents Under Conventional Whole Cell Patch Clamp Conditions
To test the hypothesis that depletion of Ca2+ buffering contributes to Ca2+-dependent inactivation of TRPM4, we compared channel activity recorded in cerebral arterial myocytes under perforated and conventional whole cell configuration with EGTA (10 mM) included in the pipette. Under perforated patch clamp conditions, TICCs have a frequency of 20.1 ± 1.6 Hz (n = 5) (Figure 3A). To better characterize the channel activity, a peak amplitude histogram was constructed (Figure 3B) and 5 peaks (solid line) were identified at −1.70, −3.43, −5.02, −6.5, and −8.49 pA and are consistent with the calculated unitary current amplitude for 1 (−1.7 pA), 2 (−3.4 pA), 3 (−5.1 pA), 4 (−6.8 pA), and 5 (−8.5 pA) TRPM4 channel openings as well as our previous findings [13]. These currents were compared to those recorded using the whole cell configuration with 10 mM EGTA added to the pipette solutions. Currents recorded under these conditions (Figure 3C) are reminiscent of TICCs recorded under perforated patch clamp conditions (Figure 3A). For clarity, we refer to TICC-like currents recorded using the conventional whole cell configuration as “whole-cell TICCs”. Whole-cell TICCs have a frequency of 20.1 ± 2.0 Hz (n = 5) (Figure 3C). A peak amplitude histogram was constructed (Figure 3D) and 4 peaks (solid line) were identified with the calculated current amplitude for multiple TRPM4 channel openings. The peaks in the histogram occur at −1.7, −3.3, −5.1, and −6.8 pA and are consistent with the calculated unitary current amplitude for TRPM4 and peaks we observed under perforated patch clamp conditions (Figure 3B). The correspondence of event frequency and peak amplitude histograms between the two methods suggests that whole-cell TICCs are identical to TICCs recorded under the perforated patch clamp conditions.
Figure 3. Sustained Transient Cation Channel Activity in Freshly Isolated Smooth Muscle Cells.
A: Representative perforated patch clamp recordings of Transient Inward Cation Currents (TICC) obtained using the amphotericin B perforated patch configuration. Representative of 5 cells. Insert shows expanded time scale. B: Peak amplitude histogram of TICC activity recorded from freshly isolated smooth muscle (0.1 pA bins) under perforated patch clamp conditions. Data are fitted with multiple Gaussian functions. The solid-line peaks match calculated current amplitude for TRPM4 channel openings. The dash-line peaks do not match with calculated current amplitude for TRPM4 channel openings. C: Representative conventional whole cell patch clamp recording of whole-cell TICC activity with 10 mM EGTA included in the pipette solution. D: Peak amplitude histogram of whole-cell TICC activity recorded from freshly isolated smooth muscle (0.1 pA bins) with 10 mM EGTA in the pipette solution. Data are fitted with multiple Gaussian functions, with the solid-line and dash-line peaks matching and not matching, respectively, with the calculated current amplitude for TRPM4 channel openings.
Biophysical properties of whole-cell TICCs were compared with those of TICCs recorded under perforated patch clamp conditions and TRPM4 currents recorded using conventional whole cell and inside-out configurations. To rule out the influence of K+ channels, recordings were made in the presence of the broad-spectrum K+ channel blocker tetraethylammonium (TEA, 10 mM). TEA had no effect on the total open probability (NPo) of current activity (n=4), demonstrating that these cation currents are independent of K+ channel activity (Figure 4A). Whole-cell TICCs were eliminated when Na+ in the bathing solution was replaced with the non-permeable cation N-methyl-D-glucamine (NMDG) (Figure 4B), indicating that currents are conducted by Na+ ions, consistent with the selectivity of TRPM4 for monovalent cations. To examine the voltage dependence of whole-cell TICCs, currents were recorded in the presence of TEA and at different holding potentials, with the mean current amplitude (I) plotted as a function of membrane potential (V). Similar to the I/V relationships reported for TRPM4 obtained under conventional conditions [3, 4], whole-cell TICCs displayed modest inward and outward rectification, and reversed at 5–10 mV, consistent with the reversal potential for monovalent cations (7.7 mV) calculated for solutions used in these experiments (Figure 4C).
Figure 4. Biophysical Properties of Whole-Cell TICC Activity.
A: Representative trace and summary data of whole-cell TICC activity in the presence of the tetraethylammonium (TEA) (10 mM, n=4). B: Representative trace and summary data of whole-cell TICC activity with Na+ replaced with the non-permeabale cation N-methyl-D-glucamine (NMDG), n=9, *P≤0.05 vs. Control. C: Sample traces of whole-cell TICC recordings obtained at holding potentials (VH) from +80 to −70 mV in the presence of TEA. Average current amplitude to voltage relationship (I/V) for cells (n=3–5) with symmetrical total cations solutions under whole cell patch clamp conditions.
Pharmacological TRPM4 inhibitors were employed to provide further evidence that whole-cell TICCs result from TRPM4 channel activity. Fluflenamic acid reportedly inhibits TRPM4 (EC50 = 2.8 μM) and TRPM5 (EC50 = 24.5 μM) currents [32]. Whole-cell TICC activity was diminished following the administration of fluflenamic acid (10 μM) (Figure 5A). The selective TRPM4 blocker 9-phenanthrol (30 μM) also attenuated whole-cell TICC activity (Figure 5B). At the concentration used for this study, 9-phenanthrol inhibits TRPM4 and not TRPM5 [33], TRPC3, TRPC6, BKCa, KIR, KV, and L-type Ca2+ channels [2]. These findings demonstrate that whole-cell TICC activity is suppressed by TRPM4 blockers, suggesting that these currents are carried by TRPM4 channels.
Figure 5. Whole-Cell TICCs Represent TRPM4 Channel Activity.
A: Representative trace and summary data of whole-cell TICC activity in the presence of fluflenamic acid (10 μM, n=3), a blocker of TRPM4 activity. B: Representative traces and summary data of whole-cell TICC activity in the presence of the selective TRPM4 blocker 9-phenanthrol (30 μM, n=3). *P≤0.05 vs. control. C: Representative recordings and summary data of whole-cell TICC activity from a cell isolated from arteries treated with control (top; n=10) and TRPM4 (bottom n=10) siRNA. *P≤0.05 vs. control siRNA.
To provide additional evidence for a link between TRPM4 and whole-cell TICCs, TRPM4 expression was silenced using siRNA. We previously reported that TRPM4 siRNA specifically downregulates TRPM4 mRNA and protein expression but had no effect on TRPC3 or TRPC6 expression [13]. We found that whole-cell TICCs were present in arterial smooth muscle cells isolated from arteries treated with control siRNA, whereas treatment with TRPM4-specific siRNA nearly abolished these currents (Figure 5C). Thus, whole-cell TICCs have properties similar to TICCs recorded under perforated patch clamp conditions and TRPM4 currents recorded using conventional methods. Furthermore, whole-cell TICC activity is attenuated by TRPM4 blockers and diminished in cells treated with TRPM4 siRNA. These finding indicate that the molecular identity of the channel responsible for whole-cell TICCs in native smooth muscle cells is TRPM4. More importantly, our findings indicate that restoration of intracellular Ca2+ buffering to endogenous levels is sufficient to prevent Ca2+-dependent inactivation of TRPM4, suggesting that endogenous Ca2+ buffers are essential for preventing TRPM4 channel inactivation in smooth muscle cells under native conditions.
3.4. Whole-Cell TICCs are Activated by IP3R-dependent SR Ca2+ Release
A prior study from our lab showed that in cerebral artery smooth muscle cells patch clamped in the perforated patch configuration, TRPM4 is activated by Ca2+ release from IP3R [13]. To examine Ca2+-dependent activation of TRPM4 channels under cytosolic EGTA-buffered conditions, we recorded whole-cell TICC activity following the removal of extracellular Ca2+ and during pharmacological manipulation of SR Ca2+ stores. Removal of extracellular Ca2+ did not acutely disrupt whole-cell TICC activity, but extended exposure (3 minutes) to Ca2+-free bathing solution resulted in decreased activity (Figure 6A). Following disruption of SR Ca2+ stores by the inhibition of SERCA pumps with cyclopiazonic acid (CPA, 30 μM), we observed a decrease in whole-cell TICC activity (Figure 6B), suggesting that SR Ca2+ release is still necessary for activation of TRPM4 channels under these conditions. Consistent with our previous report [13], inhibition of ryanodine receptors by ryanodine (50 μM) had no effect (Figure 6D), while blocking IP3R with Xestospongin C (1 μM) greatly attenuated whole-cell TICC activity (Figure 6C). To further characterize the role of IP3R, we employed the membrane permeable IP3 analog, Bt-IP3 [34] to activate IP3R. We observed a dose-dependent increase in TICC activity in the presence of Bt-IP3 (Figure 6E), which was blocked in the presence of Xestospongin C. These data provide additional evidence for the activation of TRPM4 by Ca2+ released from IP3R. Overall, these findings suggest that inclusion of EGTA (10 mM) in the pipette solution does not disrupt activation of TRPM4 by IP3R-mediated Ca2+ release but does provide sufficient buffering capacity to prevent rapid Ca2+-dependent inactivation of the channel.
Figure 6. Whole-Cell TICCs are Activated by IP3R-dependent SR Ca2+ Release.
A: Representative trace and summary data of whole-cell TICC activity in the presence of extracellular Ca2+ (n=4) and at 45 sec [1] (n=4) and ~3 minutes [2] (n=3) after extracellular Ca2+ is removed. B: Representative trace and summary data of whole-cell TICC activity in the presence of the SERCA pump blocker cyclopiazonic acid (CPA, 30 μM, n=3). C: Representative trace and summary data of whole-cell TICC activity in the presence of the specific ryanodine receptor blocker ryanodine (50 μM, n=3). D: Representative trace and summary data of whole-cell TICC activity in the presence of the specific IP3R blocker Xestospongin C (1 μM, n=3). *P≤0.05 vs. control. E: Representative trace and dose response of the effects of the membrane permeable IP3 analog, Bt-IP3 (10 μM) on whole-cell TICC activity (EC50 = 1.6 μM); n = 3–5 per dose. F: Representative trace and summary data of whole-cell TICC activity in the presence of Xestospongin C (1 μM, n=3), and Bt-IP3 (10 μM, n=4). *P≤0.05 vs. control.
3.5. Whole-Cell TICC Activity is Modulated by the Cytosolic Buffering with BAPTA
Our findings show that the activation of plasma membrane TRPM4 channels by Ca2+ released from IP3Rs on the SR membrane is not blocked when EGTA (10 mM) is included in the intracellular solution, suggesting that the two channels are in close proximity. The effectiveness of Ca2+ buffers within a given volume is dependent on the Ca2+ affinity, binding rates, and mobility of the buffer [29]. EGTA and BAPTA have similar mobility and steady-state binding affinities for Ca2+ (Table 1) and differ only in the binding kinetics, i.e. BAPTA binds Ca2+ approximately 100 times faster than EGTA [35]. Comparing the buffering effectiveness of BAPTA versus an identical concentration of EGTA has previously been used to estimate the volume buffered within the range of tens of nanometers [35, 36]. To further characterize the Ca2+ domains between IP3Rs and TRPM4, we modeled the effects of different concentrations of BAPTA on the linear spread of Ca2+ released from a single IP3R, as described above. We used buffering parameters previously reported for the diffusion coefficient, Ca2+ affinity, dissociation constant, and Ca2+ on- and off-rates for BAPTA (Table 1) [29]. With an intracellular [BAPTA] of 0.1 mM, our model predicts that the spatial spread of Ca2+ from a point source will be nearly identical to that of an endogenous buffering environment, whereas when [BAPTA] was increased to 10 mM, our model predicts that the spatial spread of Ca2+ is much more restricted (Figure 7).
Figure 7. Endogenous Ca2+ Buffering Can be Mimicked with BAPTA.
Modeling the effects of endogenous buffering capacity and different concentrations (0.1 and 10 mM) of the fast Ca2+ chelator BAPTA on [Ca2+] as a function of distance from a single IP3R Ca2+ release site.
To test the predictions of our cytosolic Ca2+ buffering model we examined Ca2+-dependent activation and inactivation of TRPM4 channel activity. Different concentrations of EGTA and BAPTA were included in the pipette solution, and whole-cell TICC activity was recorded from freshly isolated cerebral artery myocytes. A graphical representation of the hypothesized effects of these buffering conditions on Ca2+ levels at the plasma membrane and TRPM4 activity is shown in Figure 8B. We found that when EGTA (10 mM) and BAPTA (0.1 mM), which emulate the effects of endogenous Ca2+ buffering (Figure 8B), were included in the pipette solution, whole-cell TICC activity did not differ from that observed when cells were patch clamped under perforated patch conditions (Figure 8A). When EGTA was included in the patch pipette at concentrations lower than 10 mM, whole-cell TICC activity was significantly less than that recorded under perforated patch conditions (Figure 8A), suggesting that buffering under these conditions was insufficient to prevent Ca2+-dependent inactivation of TRPM4 channel activity (Figure 8B). Inclusion of BAPTA at 1 or 10mM diminished channel activity (Figure 8A), suggesting that TRPM4 channels are located very near to, but are not physically coupled with IP3Rs [37, 38]. Our model predicts that the spatial spread of Ca2+ is restricted under these conditions (Figure 8B), suggesting that Ca2+ levels within the plasma membrane and SR junctions are insufficient to activate channel activity. These data demonstrate, in agreement with our modeling predictions, that EGTA (10 mM) and BAPTA (0.1 mM) are sufficient to restore endogenous Ca2+ buffering lost during cellular dialysis under whole cell patch clamp conditions and can prevent rapid Ca2+-dependent inactivation of the channel.
Figure 8. Effects of Buffer Concentration on Whole-Cell TICC Activity.
A: Representative traces of channel activity from recordings under perforated patch clamp (PP) and whole-cell configuration with different concentration of EGTA or BAPTA added to the pipette solution. B: Summary data showing average total open probabilities (NPo) of whole-cell TICC activity at different concentrations of Ca2+ buffers; n = 5–7 per group. *P≤0.05 vs. PP, #P≤0.05 vs. 10 mM EGTA, and †P≤0.05 vs. 0.1 mM BAPTA. C: Schematic representation of the Ca2+ spread and hypothetical activation and inactivation of TRPM4 following the Ca2+ release from a single IP3R.
3.6. TRPM4 and IP3R are Proximate
Our functional electrophysiological data suggest that the activation of plasma membrane TRPM4 channels by Ca2+ released from IP3Rs on the SR membrane requires that the two channels and membranes be in close proximity. To test this idea and assess the relative localization of TRPM4 and IP3R in cerebral artery myocytes, isolated cells were immunolabeled with TRPM4 and IP3R-specific antibodies, and the SR and plasma membranes were fluorescently stained with selective dyes. In cells stained with selective dyes, the SR membrane is plainly visible and is clearly separated from the plasma membrane, demonstrating dye specificity and the close proximity of the two membranes (Figure 9A, insert a). Separation of the SR membrane from the plasma membrane is apparent in intensity plots along a line segment as distinct fluorescence peaks corresponding to the plasma (red) and SR (green) membranes (Figure 9A, insert b). When immunolabeling and membrane staining are combined, we observe that TRPM4 channels are localized to the plasma membrane, and IP3Rs are expressed in the SR membrane approaching the plasma membrane (Figure 9B–E). Dual immunolabeling experiments confirm the proximal localization of TRPM4 channels and IP3R at distinct junction sites (Figure 9F, inserts a and b). These findings demonstrate the presence of SR to plasma membrane (SR/PM) junctions where IP3R channels are present in the SR membrane proximal to TRPM4 channels localized in the plasma membrane.
Figure 9. Localization of TRPM4 and IP3R in Freshly Isolated Smooth Muscle Cells.
A: Representative images demonstrate the specific fluorescent staining of the sarcoplasmic reticulum (SR, green) and plasma membrane (red) in a freshly isolated smooth muscle cell. Merged image shows little overlap of the SR and plasma membrane. Bar = 5 μm. (a) Higher magnification of insert illustrating specific staining of SR and plasma membrane. (b) Intensity profile of SR and plasma membrane fluorescence along the line segment. B: Representative images of an isolated smooth muscle cell immunolabeled for TRPM4 (green) and stained for the plasma membrane (red). Bar = 10 μm. Bottom: High magnification insert demonstrating the co-localization (yellow) of TRPM4 with the plasma membrane. C: Representative images of an isolated smooth muscle cell immunolabeled for TRPM4 (green) and stained for the SR membrane (red). Bar = 10 μm. Bottom: High magnification insert demonstrating separation of TRPM4 and the SR membrane. D: Representative images of an isolated smooth muscle cell immunolabeled for IP3R (green) and stained for the plasma membrane (red). Bar = 10 μm. Bottom: High magnification insert demonstrating separation of IP3R and the plasma membrane. E: Representative images of an isolated smooth muscle cell immunolabeled for IP3R (green) and stained for the SR membrane (red) Bar = 10 μm. Bottom: High magnification insert demonstrating the co-localization of IP3R with the SR membrane (yellow). F: Representative images of an isolated smooth muscle cell immunolabeled for IP3R (green) and TRPM4 (red). Bar = 10 μm. (a and b) High magnification of inserts illustrating specific localization of TRPM4 (red, outside) and IP3R (green, inside). Notice the distinct points of co-localization (arrowhead).
4. DISCUSSION
The current study demonstrates the importance of endogenous intracellular Ca2+ buffering for maintaining TRPM4 activity in cerebral artery myocytes. Our major findings are: (1) restoration of endogenous Ca2+ buffering capacity lost when native smooth muscle cells are dialyzed under conventional whole cell conditions prevents time-dependent inactivation of whole-cell TICCs; (2) the biophysical properties of whole-cell TICCs are consistent with those of TICCs recorded using the perforated patch clamp configuration and TRPM4 currents recorded using conventional methods; (3) the pharmacological and molecular profile of currents recorded under whole-cell conditions indicates that these novel currents are conducted by TRPM4 channels; and (4) high concentrations of BAPTA can extinguish the Ca2+ signaling required for the activation of TRPM4, suggesting that TRPM4 channels are not physically coupled to IP3R but are located within 50 nm. These findings demonstrate for the first time that cytosolic Ca2+ buffering influences membrane excitability by maintaining and modulating TRPM4 channel activity in native cerebral artery smooth muscle cells.
Many of the biophysical and pharmacological characteristics of the novel whole-cell TICCs reported here are identical to those we previously reported for TICCs recorded under perforated patch clamp conditions [13], and those described for TRPM4 channels recorded under conventional patch clamp conditions. For example, whole-cell TICCs recorded from native cerebral artery myocytes have the same frequency of occurrence (20.1 ± 2.0 Hz, n = 5) as TICCs recoded under perforated patch clamp conditions (20.1 ± 1.7 Hz, n = 5) and are in agreement with the reported unitary conductance of TRPM4 [39–41]. Whole-cell TICCs reversed at a membrane potential near 0 mV in symmetrical cationic solutions and substitution of Na+ with the impermeant cation NMDG in the bathing solution completely blocked channel activity, consistent with TRPM4’s selectivity for monovalent cations [3, 4]. We also found that whole-cell TICC activity was significantly less following administration of TRPM4 blockers, including the selective compound 9-phenanthrol [2, 13, 33], and in cells isolated from arteries treated with TRPM4-specific siRNA. Thus, we conclude that TICCs recorded under our whole cell conditions represent authentic TRPM4 activity in native cerebral artery myocytes.
The current findings indicate that the I/V relationship of TRPM4 is strongly influenced by the patch clamp configuration. Single channel recordings for TRPM4 obtained from inside-out patches in symmetrical cation solutions have a linear current to voltage relationship [1], while currents obtained using the conventional whole-cell configuration with similar solutions are dually rectifying [3, 4]. In our previous work, we reported that under perforated patch clamp conditions with physiological bathing solution, TICCs exhibited modest inward rectification at negative potentials and a small non-rectifying outward current at positive potentials [13]. In the current study, whole-cell TICC activity exhibits dual rectification, similar to that observed under conventional whole cell recording conditions. These discrepancies are likely a result of cellular dialysis. TRPM4 currents are blocked by the endogenous polyamine spermine [42, 43], which is removed by dialysis under whole cell conditions. Polyamine block is responsible for rectification of inwardly-rectifying K+ (KIR) channels in vascular smooth muscle cells [44, 45], and we propose that this effect accounts for TRPM4 current rectification under native conditions.
TRPM4 activity is necessary for pressure-induced smooth muscle vasoconstriction in vitro [1, 2, 4] and autoregulation of cerebral blood flow in vivo [46], demonstrating that the channel is a critical mediator of vascular function. However, rapid Ca2+-dependent desensitization of TRPM4 currents when recorded under conventional whole cell and inside-out patch clamp conditions hindered our understanding of the regulatory mechanisms of the channel under native conditions. TRPM4 activity can be prolonged by inhibition of PLC or by inclusion of the PIP2 in the intracellular solution [7, 10]. These findings suggest that high intracellular Ca2+levels (10–100 μM) typically used to initiate and record TRPM4 current in conventional whole cell and inside-out configurations activates a Ca2+-dependent PLC isoform, leading to TRPM4 inactivation by depleting PIP2 levels. Additionally, TRPM4 activity does not inactivate when recorded under perforated patch clamp conditions when the cytosolic environment is maintained [13, 47]. In the current study, we investigated the role of endogenous Ca2+ buffering in this process and found that when Ca2+ buffers are not present in the intracellular solution, whole-cell TICCs exhibit time-dependent inactivation with kinetics similar to those observed for TRPM4-expressing cultured cells patch clamped using the whole cell configuration and with 100 μM free Ca2+ included in the intracellular solution (Figure 1). We hypothesized that when endogenous free Ca2+ buffering mechanisms are disrupted during cell dialysis under conventional whole cell conditions, increases in cytosolic [Ca2+] resulting from intrinsic Ca2+ influx or release from the SR can also cause Ca2+-dependent inactivation of TRPM4. To test this possibility, we modeled the effects of endogenous Ca2+ buffers on the spatial spread of Ca2+ from a point source. The endogenous and exogenous buffering parameters used for our model are based on values reported in the literature, which have a wide range and may over- or under-estimate buffering capacity. Additionally, the model is based on buffering parameters for whole cell conditions, which may differ from those within specific subcellular nano or microdomains. Lastly, as a first order approximation, we only considered the endogenous buffering parameters of the most abundant Ca2+ binding protein, calmodulin, at a total intracellular concentration of 40 μM [28, 48]. However, even with the possible inaccuracies of our model, we were able to accurately predict that addition of 10 mM EGTA or 0.1 mM BAPTA to the intracellular solution restores TRPM4 activity to that observed under native Ca2+ buffering conditions in the perforated patch configuration. Thus, these findings suggest that levels of calmodulin, and perhaps other Ca2+-binding proteins like calpain and troponin C, together would equal a buffering capacity similar to 10 mM EGTA. Furthermore, if only free Ca2+ binding proteins are lost during cellular dialysis under whole cell conditions, our findings suggest that anchored Ca2+ homeostasis-important ion channels like PMCA, Na+/Ca2+ exchangers, and SERCA pumps play a minor role in preventing the Ca2+-dependent inactivation of TRPM4 channels under physiological conditions. Additionally, physical interaction of calmodulin with the c-terminus of TRPM4 is essential for Ca2+ sensitivity and activation of the channel in physiological range of intracellular Ca2+ concentrations [49]. Our ability to rescue channel activity following cell dialysis suggests that calmodulin required for channel activation is constitutively bound to the channel itself and not free within the cytoplasm. This is consistent with work from Nilius et al., reporting five possible Ca2+-dependent calmodulin interacting domains on TRPM4, two at the n-terminus and three at the c-terminus [49]. Our findings clearly demonstrate that maintenance of TRPM4 activity is a novel role for free endogenous Ca2+ buffering proteins, a property that may regulate critical features of smooth muscle cell excitability and contractility.
Proper maintenance of SR Ca2+ stores is necessary for many cellular functions. SERCA pumps actively siphon Ca2+ from the cytoplasm back into the SR lumen, refilling internal Ca2+ stores. This process of recycling Ca2+ is important for maintaining the transmembrane Ca2+ gradient of low cytosolic and high SR lumen Ca2+ levels. Inhibition of the SERCA pumps by CPA disrupts the Ca2+ refilling of the SR, and Ca2+ is leaked from internal stores into the cytoplasm, disrupting the Ca2+ gradient. In many types of cells, SR Ca2+ store depletion activates store operated Ca2+ entry channels (SOCs) [56]. However, in the current study, we did not record SOC activity following the depletion of internal Ca2+ stores with CPA. This observation is consistent with prior studies that failed to demonstrate SOC activity in contractile cerebral artery smooth muscle cells [34, 57–60]. Consistent with our previous reports using perforated patch clamp [13], whole-cell TICC activity quickly decreased following the pharmacological inhibition of SERCA pumps by CPA (30 μM). It seems likely that depletion of SR Ca2+ stores translates to a loss of Ca2+ release and decreased activation of Ca2+-sensitive ion channels. For example, the large conductance Ca2+-activated potassium channel (BKCa) is stimulated by Ca2+ release from ryanodine receptors located on the SR membrane to produce spontaneous transient outward currents (STOCs) [17, 50]. Store depletion significantly decreases Ca2+ dependent activation of BKCa channels and STOC activity is abolished within 40–120 seconds following CPA administration [51–53]. Thus, the time required for BKCa inactivation in response to CPA is similar to that observed for TRPM4 inactivation following this treatment in the current study, suggesting that loss of TRPM4 activity results from diminished SR Ca2+-release. Alternatively, it is possible that CPA-induced Ca2+ leak from internal stores elevates [Ca2+] within small cytoplasmic spaces proximal to the plasma membrane to levels that lead to Ca2+-dependent inactivation of TRPM4 channels. Consistent with this possibility, reports using fluorescent Ca2+ indicators in smooth muscle cells show an immediate increase in cytosolic Ca2+, presumably due to Ca2+ leak from the SR, reaching maximum [Ca2+]i within 40 – 300 seconds [54, 55]. This subsequent increase in global calcium may lead to TRPM4 channel inactivation and the relative rapid loss of TICC activity. Regardless of the exact mechanisms, our findings clearly show that intact SR Ca2+ stores are required for TRPM4 activity in native cerebral artery myocytes.
Differential modulation of TRPM4 channel activity by the slow Ca2+ buffer EGTA and the fast Ca2+ buffer BAPTA provides strong evidence that TRPM4 channels are proximal and functionally coupled with IP3R through Ca2+ signaling events. BAPTA and EGTA have similar steady-state Ca2+ binding affinities, but significantly different binding rate constants (Table 1) [27]. Based on this divergence, comparison of BAPTA- and EGTA-dependent disruptions of Ca2+-dependent processes can be used to classify localized regions of elevated Ca2+ as “Ca2+ nanodomains” or “Ca2+ microdomains” [35, 36, 61]. Ca2+ microdomains, with a Ca2+ source-to-sensor distance of greater than 50 nm, are defined by Ca2+-dependent responses that are equally disrupted by identical concentrations of BAPTA and EGTA [35, 61]. In contrast, Ca2+ nanodomains, with a Ca2+ source-to-sensor distance less than 50 nm, are defined by Ca2+-dependent responses that are significantly interfered with by BAPTA, but not by equal concentrations of EGTA [35, 61]. Our findings demonstrating that whole-cell TICC activity can be recorded in the presence of 10 mM EGTA but not in 10 mM BAPTA suggest that IP3R-mediated activation of TRPM4 channels occur in Ca2+ nanodomains, and that TRPM4 channels and IP3R are less than 50 nm apart. The current estimate of the junctional spaces between plasma membrane caveolae and SR membrane projections is 15 ± 7 nm [62, 63]. Therefore, our findings suggest that IP3R and TRPM4 channels are localized within these small spaces. Additionally, recent studies have reported physical coupling of IP3R and the canonical TRP channel, TRPC3, through the caveolae scaffolding protein caveolin-1 in smooth muscle cells [34, 37, 38]. Inhbition of whole-cell TICCs by Ca2+ chelation with BAPTA provides electrophysiological evidence that plasma membrane TRPM4 channels are not physically coupled to IP3R located in the SR, but rather are activated by Ca2+ release events from IP3R located less than 50 nm away from TRPM4 channels on the plasma membrane.
In conclusion, our findings suggest that endogenous intracellular Ca2+ buffering and SR Ca2+ recycling are essential for maintenance of TRPM4 channels activity in cerebral artery smooth muscle cells. Furthermore, we demonstrate that IP3R-mediated activation of TRPM4 channels occur within Ca2+ nanodomains created by SR/plasma membrane junctions. Lastly, the regulation of smooth muscle cytosolic Ca2+ buffering and the SR/plasma membrane architecture play integral roles in excitability and arterial function through modulation of TRPM4 channel activity.
SUMMARY.
In smooth muscle cells, regulation of intracellular Ca2+ concentration by endogenous buffering is vital for the maintenance of many basic cellular functions. The melastatin transient receptor potential (TRP) channel, TRPM4, is essential for pressure-induced membrane depolarization and vasoconstriction. The channel is activated by Ca2+ released from internal stores, but prolonged exposure to high global Ca2+ causes the channel to quickly inactivate. Endogenous buffering insures that Ca2+ release events are short and localized. However, the role of endogenous Ca2+ buffering in regulation of TRPM4 activity has not been reported. Using computer modeling and patch clamp electrophysiology, we examined the effects of manipulating intracellular Ca2+ buffering on TRPM4 channel activity. We demonstrate that TRPM4 channels are activated by small Ca2+ domains created from Ca2+ release sites found in close proximity to the plasma membrane, and that intracellular Ca2+ buffering influences smooth muscle excitability and arterial function through modulation of TRPM4 channel activity.
Acknowledgments
We thank Kristen Middleton, Ying Yang, and Alainna McPhaul for technical assistance and Dr. Gregory C. Amberg and Michelle N. Sullivan for critical comments on the manuscript. This work was supported by NIH grants RO1HL091905 (SE) and F31HL094145 (ALG); National American Heart Association Scientist Development Grants AHA0535226N (SE); and a fellowship from the McNair Scholars Foundation (ALG).
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Earley S, Waldron BJ, Brayden JE. Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries. Circ Res. 2004;95:922–929. doi: 10.1161/01.RES.0000147311.54833.03. [DOI] [PubMed] [Google Scholar]
- 2.Gonzales AL, Garcia ZI, Amberg GC, Earley S. Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am J Physiol Cell Physiol. 2010;299:C1195–1202. doi: 10.1152/ajpcell.00269.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, Wissenbach U, Flockerzi V. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003;278:30813–30820. doi: 10.1074/jbc.M305127200. [DOI] [PubMed] [Google Scholar]
- 4.Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol. 2007;292:H2613–2622. doi: 10.1152/ajpheart.01286.2006. [DOI] [PubMed] [Google Scholar]
- 5.Demion M, Bois P, Launay P, Guinamard R. TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells. Cardiovasc Res. 2007;73:531–538. doi: 10.1016/j.cardiores.2006.11.023. [DOI] [PubMed] [Google Scholar]
- 6.Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol. 2007;292:H2613–2622. doi: 10.1152/ajpheart.01286.2006. [DOI] [PubMed] [Google Scholar]
- 7.Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R, Voets T. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006;25:467–478. doi: 10.1038/sj.emboj.7600963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet JP. TRPM4 Regulates Calcium Oscillations After T Cell Activation. Science. 2004;306:1374–1377. doi: 10.1126/science.1098845. [DOI] [PubMed] [Google Scholar]
- 9.Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX. Regulation of the Ca2+ Sensitivity of the Nonselective Cation Channel TRPM4. Journal of Biological Chemistry. 2005;280:6423–6433. doi: 10.1074/jbc.M411089200. [DOI] [PubMed] [Google Scholar]
- 10.Zhang Z, Okawa H, Wang Y, Liman ER. Phosphatidylinositol 4,5-bisphosphate rescues TRPM4 channels from desensitization. J Biol Chem. 2005;280:39185–39192. doi: 10.1074/jbc.M506965200. [DOI] [PubMed] [Google Scholar]
- 11.Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R, Voets T. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006;25:467–478. doi: 10.1038/sj.emboj.7600963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev. 2000;80:1291–1335. doi: 10.1152/physrev.2000.80.4.1291. [DOI] [PubMed] [Google Scholar]
- 13.Gonzales AL, Amberg GC, Earley S. Ca2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol. 2010;299:C279–288. doi: 10.1152/ajpcell.00550.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Navedo MF, Amberg GC, Votaw VS, Santana LF. Constitutively active L-type Ca2+ channels. Proc Natl Acad Sci U S A. 2005;102:11112–11117. doi: 10.1073/pnas.0500360102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Santana LF, Navedo MF. Molecular and biophysical mechanisms of Ca2+ sparklets in smooth muscle. J Mol Cell Cardiol. 2009;47:436–444. doi: 10.1016/j.yjmcc.2009.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Boittin FX, Coussin F, Morel JL, Halet G, Macrez N, Mironneau J. Ca(2+) signals mediated by Ins(1,4,5)P(3)-gated channels in rat ureteric myocytes. Biochem J. 2000;349:323–332. doi: 10.1042/0264-6021:3490323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jaggar JH, Wellman GC, Heppner TJ, Porter VA, Perez GJ, Gollasch M, Kleppisch T, Rubart M, Stevenson AS, Lederer WJ, Knot HJ, Bonev AD, Nelson MT. Ca2+ channels, ryanodine receptors and Ca(2+)-activated K+ channels: a functional unit for regulating arterial tone. Acta Physiol Scand. 1998;164:577–587. doi: 10.1046/j.1365-201X.1998.00462.x. [DOI] [PubMed] [Google Scholar]
- 18.Mironneau J, Arnaudeau S, Macrez-Lepretre N, Boittin FX. Ca2+ sparks and Ca2+ waves activate different Ca(2+)-dependent ion channels in single myocytes from rat portal vein. Cell Calcium. 1996;20:153–160. doi: 10.1016/s0143-4160(96)90104-9. [DOI] [PubMed] [Google Scholar]
- 19.Yao Y, Choi J, Parker I. Quantal puffs of intracellular Ca2+ evoked by inositol trisphosphate in Xenopus oocytes. J Physiol. 1995;482(Pt 3):533–553. doi: 10.1113/jphysiol.1995.sp020538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Marin J, Encabo A, Briones A, Garcia-Cohen EC, Alonso MJ. Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: calcium pumps. Life Sci. 1999;64:279–303. doi: 10.1016/s0024-3205(98)00393-2. [DOI] [PubMed] [Google Scholar]
- 21.Toescu EC. Temporal and spatial heterogeneities of Ca2+ signaling: mechanisms and physiological roles. Am J Physiol. 1995;269:G173–185. doi: 10.1152/ajpgi.1995.269.2.G173. [DOI] [PubMed] [Google Scholar]
- 22.Wellman GC, Nelson MT. Signaling between SR and plasmalemma in smooth muscle: sparks and the activation of Ca2+-sensitive ion channels. Cell Calcium. 2003;34:211–229. doi: 10.1016/s0143-4160(03)00124-6. [DOI] [PubMed] [Google Scholar]
- 23.Crnich R, Amberg GC, Leo MD, Gonzales AL, Tamkun MM, Jaggar JH, Earley S. Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2010;299:C682–694. doi: 10.1152/ajpcell.00101.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Matveev V, Zucker RS, Sherman A. Facilitation through buffer saturation: constraints on endogenous buffering properties. Biophys J. 2004;86:2691–2709. doi: 10.1016/S0006-3495(04)74324-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Smith IF, Parker I. Imaging the quantal substructure of single IP3R channel activity during Ca2+ puffs in intact mammalian cells. Proc Natl Acad Sci U S A. 2009;106:6404–6409. doi: 10.1073/pnas.0810799106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bruno L, Solovey G, Ventura AC, Dargan S, Dawson SP. Quantifying calcium fluxes underlying calcium puffs in Xenopus laevis oocytes. Cell Calcium. 2010;47:273–286. doi: 10.1016/j.ceca.2009.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Allbritton NL, Meyer T, Stryer L. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science. 1992;258:1812–1815. doi: 10.1126/science.1465619. [DOI] [PubMed] [Google Scholar]
- 28.Zimmermann B, Somlyo AV, Ellis-Davies GC, Kaplan JH, Somlyo AP. Kinetics of prephosphorylation reactions and myosin light chain phosphorylation in smooth muscle. Flash photolysis studies with caged calcium and caged ATP. J Biol Chem. 1995;270:23966–23974. doi: 10.1074/jbc.270.41.23966. [DOI] [PubMed] [Google Scholar]
- 29.Naraghi M, Neher E. Linearized buffered Ca2+ diffusion in microdomains and its implications for calculation of [Ca2+] at the mouth of a calcium channel. J Neurosci. 1997;17:6961–6973. doi: 10.1523/JNEUROSCI.17-18-06961.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Falke JJ, Drake SK, Hazard AL, Peersen OB. Molecular tuning of ion binding to calcium signaling proteins. Q Rev Biophys. 1994;27:219–290. doi: 10.1017/s0033583500003012. [DOI] [PubMed] [Google Scholar]
- 31.Sanabria H, Digman MA, Gratton E, Waxham MN. Spatial diffusivity and availability of intracellular calmodulin. Biophys J. 2008;95:6002–6015. doi: 10.1529/biophysj.108.138974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ullrich ND, Voets T, Prenen J, Vennekens R, Talavera K, Droogmans G, Nilius B. Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium. 2005;37:267–278. doi: 10.1016/j.ceca.2004.11.001. [DOI] [PubMed] [Google Scholar]
- 33.Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, Bois P, Guinamard R. 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol. 2008;153:1697–1705. doi: 10.1038/bjp.2008.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Xi Q, Adebiyi A, Zhao G, Chapman KE, Waters CM, Hassid A, Jaggar JH. IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release. Circ Res. 2008;102:1118–1126. doi: 10.1161/CIRCRESAHA.108.173948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Neher E. Vesicle pools and Ca2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron. 1998;20:389–399. doi: 10.1016/s0896-6273(00)80983-6. [DOI] [PubMed] [Google Scholar]
- 36.Fakler B, Adelman JP. Control of K(Ca) channels by calcium nano/microdomains. Neuron. 2008;59:873–881. doi: 10.1016/j.neuron.2008.09.001. [DOI] [PubMed] [Google Scholar]
- 37.Adebiyi A, Narayanan D, Jaggar JH. Caveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cells. J Biol Chem. 2011;286:4341–4348. doi: 10.1074/jbc.M110.179747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Adebiyi A, Zhao G, Narayanan D, Thomas-Gatewood CM, Bannister JP, Jaggar JH. Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility. Circ Res. 2010;106:1603–1612. doi: 10.1161/CIRCRESAHA.110.216804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ohya Y, Adachi N, Nakamura Y, Setoguchi M, Abe I, Fujishima M. Stretch-Activated Channels in Arterial Smooth Muscle of Genetic Hypertensive Rats. Hypertension. 1998;31:254–258. doi: 10.1161/01.hyp.31.1.254. [DOI] [PubMed] [Google Scholar]
- 40.Park KS, Kim Y, Lee YH, Earm YE, Ho WK. Mechanosensitive Cation Channels in Arterial Smooth Muscle Cells Are Activated by Diacylglycerol and Inhibited by Phospholipase C Inhibitor. Circ Res. 2003;93:557–564. doi: 10.1161/01.RES.0000093204.25499.83. [DOI] [PubMed] [Google Scholar]
- 41.WU S-N, LIN P-H, HSIEH K-S, LIU Y-C, CHIANG H-T. Behavior of Nonselective Cation Channels and Large-Conductance Ca2+-Activated K+ Channels Induced by Dynamic Changes in Membrane Stretch in Cultured Smooth Muscle Cells of Human Coronary Artery. Journal of Cardiovascular Electrophysiology. 2003;14:44–51. doi: 10.1046/j.1540-8167.2003.02040.x. [DOI] [PubMed] [Google Scholar]
- 42.Matveev BP, Matveev VB, Khalf’ian EA, Volkova MI, Gurarii LL. Regional metastases of penile cancer: optimal treatment policy. Urologiia. 2004:19–23. [PubMed] [Google Scholar]
- 43.Nilius B, Prenen J, Janssens A, Owsianik G, Wang C, Zhu MX, Voets T. The Selectivity Filter of the Cation Channel TRPM4. Journal of Biological Chemistry. 2005;280:22899–22906. doi: 10.1074/jbc.M501686200. [DOI] [PubMed] [Google Scholar]
- 44.Kashkina LM, Matveeva VA, Dyakova NA, Uvarova EN, Deichman GI. Acquisition of HP phenotype and alterations in the activity of catalase of in vitro transformed cells of different origin in the dynamics of in vivo tumor progression. Dokl Biol Sci. 2004;394:94–97. doi: 10.1023/b:dobs.0000017140.53673.30. [DOI] [PubMed] [Google Scholar]
- 45.Matveeva E, Gryczynski Z, Gryczynski I, Lakowicz JR. Immunoassays based on directional surface plasmon-coupled emission. J Immunol Methods. 2004;286:133–140. doi: 10.1016/j.jim.2003.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Reading SA, Brayden JE. Central Role of TRPM4 Channels in Cerebral Blood Flow Regulation. Stroke. 2007;38:2322–2328. doi: 10.1161/STROKEAHA.107.483404. [DOI] [PubMed] [Google Scholar]
- 47.Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92:145–159. doi: 10.1085/jgp.92.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ruegg JC, Meisheri K, Pfitzer G, Zeugner C. Skinned coronary smooth muscle: calmodulin, calcium antagonists, and cAMP influence contractility. Basic Res Cardiol. 1983;78:462–471. doi: 10.1007/BF02070169. [DOI] [PubMed] [Google Scholar]
- 49.Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX. Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem. 2005;280:6423–6433. doi: 10.1074/jbc.M411089200. [DOI] [PubMed] [Google Scholar]
- 50.Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799–822. doi: 10.1152/ajpcell.1995.268.4.C799. [DOI] [PubMed] [Google Scholar]
- 51.Burdyga TV, Wray S. The effect of cyclopiazonic acid on excitation-contraction coupling in guinea-pig ureteric smooth muscle: role of the sarcoplasmic reticulum. J Physiol. 1999;517(Pt 3):855–865. doi: 10.1111/j.1469-7793.1999.0855s.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sergeant GP, Hollywood MA, McCloskey KD, McHale NG, Thornbury KD. Role of IP(3) in modulation of spontaneous activity in pacemaker cells of rabbit urethra. Am J Physiol Cell Physiol. 2001;280:C1349–1356. doi: 10.1152/ajpcell.2001.280.5.C1349. [DOI] [PubMed] [Google Scholar]
- 53.Suzuki H, Kito Y, Fukuta H, Yamamoto Y. Dual effects of cyclopiazonic acid on excitation of circular smooth muscle isolated from the guinea-pig gastric antrum. J Smooth Muscle Res. 2002;38:23–37. doi: 10.1540/jsmr.38.23. [DOI] [PubMed] [Google Scholar]
- 54.Janiak R, Wilson SM, Montague S, Hume JR. Heterogeneity of calcium stores and elementary release events in canine pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol. 2001;280:C22–33. doi: 10.1152/ajpcell.2001.280.1.C22. [DOI] [PubMed] [Google Scholar]
- 55.Helli PB, Pertens E, Janssen LJ. Cyclopiazonic acid activates a Ca2+-permeable, nonselective cation conductance in porcine and bovine tracheal smooth muscle. J Appl Physiol. 2005;99:1759–1768. doi: 10.1152/japplphysiol.00242.2005. [DOI] [PubMed] [Google Scholar]
- 56.Putney JW. The physiological function of store-operated calcium entry. Neurochem Res. 2011;36:1157–1165. doi: 10.1007/s11064-010-0383-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Rubart M, Patlak JB, Nelson MT. Ca2+ currents in cerebral artery smooth muscle cells of rat at physiological Ca2+ concentrations. J Gen Physiol. 1996;107:459–472. doi: 10.1085/jgp.107.4.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Quayle JM, McCarron JG, Asbury JR, Nelson MT. Single calcium channels in resistance-sized cerebral arteries from rats. Am J Physiol. 1993;264:H470–478. doi: 10.1152/ajpheart.1993.264.2.H470. [DOI] [PubMed] [Google Scholar]
- 59.Worley JF, Quayle JM, Standen NB, Nelson MT. Regulation of single calcium channels in cerebral arteries by voltage, serotonin, and dihydropyridines. Am J Physiol. 1991;261:H1951–1960. doi: 10.1152/ajpheart.1991.261.6.H1951. [DOI] [PubMed] [Google Scholar]
- 60.Knot HJ, Standen NB, Nelson MT. Ryanodine receptors regulate arterial diameter and wall [Ca2+] in cerebral arteries of rat via Ca2+-dependent K+ channels. J Physiol. 1998;508(Pt 1):211–221. doi: 10.1111/j.1469-7793.1998.211br.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Augustine GJ, Santamaria F, Tanaka K. Local calcium signaling in neurons. Neuron. 2003;40:331–346. doi: 10.1016/s0896-6273(03)00639-1. [DOI] [PubMed] [Google Scholar]
- 62.Popescu LM, Gherghiceanu M, Mandache E, Cretoiu D. Caveolae in smooth muscles: nanocontacts. J Cell Mol Med. 2006;10:960–990. doi: 10.1111/j.1582-4934.2006.tb00539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Gherghiceanu M, Popescu LM. Caveolar nanospaces in smooth muscle cells. J Cell Mol Med. 2006;10:519–528. doi: 10.1111/j.1582-4934.2006.tb00417.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Klingauf J, Neher E. Modeling buffered Ca2+ diffusion near the membrane: implications for secretion in neuroendocrine cells. Biophys J. 1997;72:674–690. doi: 10.1016/s0006-3495(97)78704-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hulvershorn J, Gallant C, Wang CA, Dessy C, Morgan KG. Calmodulin levels are dynamically regulated in living vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001;280:H1422–1426. doi: 10.1152/ajpheart.2001.280.3.H1422. [DOI] [PubMed] [Google Scholar]
- 66.Dargan SL, Schwaller B, Parker I. Spatiotemporal patterning of IP3-mediated Ca2+ signals in Xenopus oocytes by Ca2+-binding proteins. J Physiol. 2004;556:447–461. doi: 10.1113/jphysiol.2003.059204. [DOI] [PMC free article] [PubMed] [Google Scholar]









